Warfarin use and fracture risk: an evidence-based mechanistic insight

Osteoporosis International

Volumn 26, Issue 3, 2015, Pages 1231-1232

  Sugiyama, T ^a   Kugimiya, F ^a   Kono, S ^a   Kim, Y T ^a   Oda, H ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 CARBOXYGLUTAMIC ACID; OSTEOCALCIN; VITAMIN K DEPENDENT CARBOXYLASE; WARFARIN; ANTICOAGULANT AGENT;

BONE MASS; BONE MINERALIZATION; BONE STRENGTH; CARBOXYLATION; CORTICAL BONE; EVIDENCE BASED PRACTICE; FRACTURE; HARDNESS; HIP FRACTURE; HUMAN; HYPOPHOSPHATEMIC RICKETS; LETTER; NEW-ONSET ATRIAL FIBRILLATION; NONHUMAN; PATIENT RISK; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROPENSITY SCORE; PROTEIN CONTENT; RIB; SPINE; SPINE FRACTURE; UNITED KINGDOM; WEIGHT BEARING; WRIST FRACTURE; ANIMAL; BONE; BONE DENSITY; CHEMICALLY INDUCED; DRUG EFFECTS; EVIDENCE BASED MEDICINE; FEMALE; MALE; MOUSE; RAT; RISK; TREATMENT OUTCOME;

ANIMALS; ANTICOAGULANTS; BONE AND BONES; BONE DENSITY; EVIDENCE-BASED MEDICINE; FEMALE; FRACTURES, BONE; HUMANS; MALE; MICE; OSTEOCALCIN; RATS; RISK; TREATMENT OUTCOME; WARFARIN;

EID: 84925517701     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-014-2912-1     Document Type: Letter

References (20)

1. Walsh JS, Newman C, Eastell R (2012) Heart drugs that affect bone. Trends Endocrinol Metab 23:163–168
2. Misra D, Zhang Y, Peloquin C, Choi HK, Kiel DP, Neogi T (2014) Incident long-term warfarin use and risk of osteoporotic fractures: propensity-score matched cohort of elders with new onset atrial fibrillation. Osteoporos Int 25:1677–1684. doi:10.1007/s00198-014-2662-0
3. Sugiyama T, Takaki T, Sakanaka K, Sadamura H, Mori K, Kato Y, Taguchi T, Saito T (2007) Warfarin-induced impairment of cortical bone material quality and compensatory adaptation of cortical bone structure to mechanical stimuli. J Endocrinol 194:213–222
4. Kavukcuoglu NB, Patterson-Buckendahl P, Mann AB (2009) Effect of osteocalcin deficiency on the nanomechanics and chemistry of mouse bones. J Mech Behav Biomed Mater 2:348–354
5. Rey-Sanchez P, Lavado-Garcia JM, Canal-Macias ML, Rodriguez-Dominguez MT, Bote-Mohedano JL, Pedrera-Zamorano JD (2011) Ultrasound bone mass in patients undergoing chronic therapy with oral anticoagulants. J Bone Miner Metab 29:546–551
6. Sugiyama T, Kawai S (2001) Carboxylation of osteocalcin may be related to bone quality: a possible mechanism of bone fracture prevention by vitamin K. J Bone Miner Metab 19:146–149
7. Sugiyama T (2013) Vitamin D and calcium supplementation to prevent fractures in adults. Ann Intern Med 159:856
8. Sugiyama T, Kawai S (2004) Quantitative ultrasound, skeletal quality, and fracture risk. Lancet 363:1076–1077
9. Shanbhogue VV, Hansen S, Folkestad L, Brixen K, Beck-Nielsen SS (2014) Bone geometry, volumetric density, microarchitecture and estimated bone strength assessed by HR-pQCT in adult patients with hypophosphatemic rickets. J Bone Miner Res. doi:10.1002/jbmr.2310
10. Sugiyama T, Taguchi T, Kawai S (2002) Adaptation of bone to mechanical loads. Lancet 359:1160
11. Sugiyama T, Yamaguchi A, Kawai S (2002) Effects of skeletal loading on bone mass and compensation mechanism in bone: a new insight into the “mechanostat” theory. J Bone Miner Metab 20:196–200
12. Jamal SA, Browner WS, Bauer DC, Cummings SR (1998) Warfarin use and risk for osteoporosis in elderly women. Study of Osteoporotic Fractures Research Group. Ann Intern Med 128:829–832
13. Caraballo PJ, Heit JA, Atkinson EJ, Silverstein MD, O’Fallon WM, Castro MR, Melton LJ 3rd (1999) Long-term use of oral anticoagulants and the risk of fracture. Arch Intern Med 159:1750–1756
14. Mamdani M, Upshur RE, Anderson G, Bartle BR, Laupacis A (2003) Warfarin therapy and risk of hip fracture among elderly patients. Pharmacotherapy 23:1–4
15. Pilon D, Castilloux AM, Dorais M, LeLorier J (2004) Oral anticoagulants and the risk of osteoporotic fractures among elderly. Pharmacoepidemiol Drug Saf 13:289–294
16. Gage BF, Birman-Deych E, Radford MJ, Nilasena DS, Binder EF (2006) Risk of osteoporotic fracture in elderly patients taking warfarin: results from the National Registry of Atrial Fibrillation 2. Arch Intern Med 166:241–246
17. Rejnmark L, Vestergaard P, Mosekilde L (2007) Fracture risk in users of oral anticoagulants: a nationwide case-control study. Int J Cardiol 118:338–344
18. Woo C, Chang LL, Ewing SK, Bauer DC, Osteoporotic Fractures in Men Study Group (2008) Single-point assessment of warfarin use and risk of osteoporosis in elderly men. J Am Geriatr Soc 56:1171–1176
19. Sato Y, Honda Y, Jun I (2010) Long-term oral anticoagulation therapy and the risk of hip fracture in patients with previous hemispheric infarction and nonrheumatic atrial fibrillation. Cerebrovasc Dis 29:73–78
20. Fusaro M, Tripepi G, Noale M, Plebani M, Zaninotto M, Piccoli A, Naso A, Miozzo D, Giannini S, Avolio M, Foschi A, Rizzo MA, Gallieni M, The Vertebral Fractures Vascular Calcifications Study Group (2014) Prevalence of vertebral fractures, vascular calcifications, and mortality in warfarin treated hemodialysis patients. Curr Vasc Pharmacol. doi:10.2174/15701611113119990146